Gains in Patient Activation Measure (PAM®) Scores at 12 Months

Identifying Attributes

Care Settings
Primary Care
Country
United States of America
Publishing Organisation
Centers for Medicare & Medicaid Services (CMS): Merit-Based Incentive Payment System (MIPS)
Type of Quality Indicator
Outcome
IOM Quality Dimension
Person-Centredness
Domain
Consumer Experience

Defining Attributes

Definition

The percentage of patients who achieve a 3-point increase in their Patient Activation Measure® (PAM®) survey score within 12 months. The outcome measure demonstrates how a clinician group performed in providing best care to its patients by quantifying the proportion of patients who had at least a 3-point score change.

Numerator

The count of eligible patients in a clinician group who had an increase of PAM survey score of at least 3 points, based on the difference between the baseline PAM survey and a second score taken between 6-12 months of the baseline.

Denominator

Eligible patients with two PAM scores no less than 6 months and not more than 12 months apart who were seen for a qualifying visit at least once during the performance period. Clinician groups would need to have two PAM scores on a minimum of 50 patients.

Exclusions

Diagnosis of Dementia, Huntington's disease, cognitive impairment or Alzheimer's disease.

Use of Risk Adjustment
No
Risk Adjustments

None

Stratifications

None

Collection and Reporting Attributes

Type of Data Collection
Administrative data, Electronic/paper chart records
Data Collection Methods

Administrative Data, Electronic Health Records, Paper Patient Medical Records and Patient-Reported Data and/or Survey Data.

Frequency of Data Collection
Frequency of Data Collection in Days
Reporting Methods
Reporting Frequency
Reporting Frequency in Days
Indicator Has Recommended Targets
No

Source and Reference Attributes

Evidence Source
Link to Measurement Tools
Quality Indicator Confirmed to be Part of a Program Used to Monitor Quality and Safety of Care Among Older People at a Population-Level between 2012-2022
Yes
Assessed by the Australian Consortium for Aged Care Collaborators as Generally Containing Good Properties (Importance and Scientific Acceptability)
No
Australian Consortium for Aged Care Endorsed
No
Identified by PHARMA-Care Project
No
Upload Date
02 December 2025